Receptors, Estrogen
Concept
Vocabulary Service
Overview
subject area of
-
17HSD 2 may be higher in African-American breast cancer and is associated with estrogen receptor-negative tumors. Academic Article
-
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years Academic Article
-
BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50 Academic Article
-
A TOXICITY IDENTIFICATION EVALUATION APPROACH TO STUDYING ESTROGENIC SUBSTANCES IN HOG MANURE AND AGRICULTURAL RUNOFF Academic Article
-
A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features Academic Article
-
A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer Academic Article
-
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer Academic Article
-
Adjuvant Therapy for Breast Cancer: We Are Solving the Puzzle, But Pieces Are Still Missing Academic Article
-
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial Academic Article
-
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials Academic Article
-
Adjuvant endocrine therapies for pre-/perimenopausal women Academic Article
-
American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004 Academic Article
-
American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004 Academic Article
-
An improved statistical approach: Can it clarify the role of new prognostic factors for breast cancer? Academic Article
-
An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays Academic Article
-
Anti-Inflammatory Effects of Tanshinone IIA on Atherosclerostic Vessels of Ovariectomized ApoE-/- Mice are Mediated by Estrogen Receptor Activation and Through the ERK Signaling Pathway Academic Article
-
Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells Academic Article
-
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials Academic Article
-
Assessing wild fish exposure to ligands for sex steroid receptors from pulp and paper mill effluents in the Biobio River Basin, Central Chile Academic Article
-
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer Academic Article
-
Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients Academic Article
-
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer Academic Article
-
BRCA2 Mutation-associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles From Tissue Microarrays Academic Article
-
Beneficial effects of resveratrol on respiratory chain defects in patients' fibroblasts involve estrogen receptor and estrogen-related receptor alpha signaling Academic Article
-
Breast Cancer Prevention with Selective Estrogen Receptor Modulators Academic Article
-
Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study Academic Article
-
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter Academic Article
-
CYP3C gene regulation by the aryl hydrocarbon and estrogen receptors in zebrafish Academic Article
-
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer Academic Article
-
Cancer Care Ontario Guideline Recommendations for Hormone Receptor Testing in Breast Cancer Academic Article
-
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer. Conference Paper
-
Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial Academic Article
-
Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From BOLERO-2 Academic Article
-
Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression Academic Article
-
Development of Patients’ Decision Aid for Older Women With Stage I Breast Cancer Considering Radiotherapy After Lumpectomy Academic Article
-
Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status Academic Article
-
Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies Academic Article
-
Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer? Academic Article
-
Downregulation of CYB5D2 is associated with breast cancer progression Academic Article
-
Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial Academic Article
-
EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry Academic Article
-
Effect Modification by Catalase Genotype Suggests a Role for Oxidative Stress in the Association of Hormone Replacement Therapy with Postmenopausal Breast Cancer Risk Academic Article
-
Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in
BOLERO-2 Academic Article
-
Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer Academic Article
-
Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort Academic Article
-
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials Academic Article
-
Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer Academic Article
-
Effects of Genistein or Soy Milk During Late Gestation and Lactation on Adult Uterine Organization in the Rat Academic Article
-
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93 Academic Article
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Academic Article
-
Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17 Conference Paper
-
Endocrine disruption mechanism of o,p′-DDT in mature male tilapia (Oreochromis niloticus) Academic Article
-
Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women Academic Article
-
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination Academic Article
-
Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer Academic Article
-
Enzyme-linked immunoabsorbent assay-detected p53 protein accumulation: a prognostic factor in a large breast cancer cohort. Conference Paper
-
ErbB Receptor Signaling and Therapeutic Resistance to Aromatase Inhibitors Conference Paper
-
Estrogen and progesterone binding sites in renal cell carcinoma Academic Article
-
Estrogen and progesterone receptor content of primary and secondary breast carcinoma: Influence of time and treatment Academic Article
-
Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer Academic Article
-
Estrogen receptor of breast cancer stem cells depending on the original breast cancers Academic Article
-
Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors Academic Article
-
Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy? Academic Article
-
Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature Academic Article
-
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis Academic Article
-
Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence Academic Article
-
Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact? Academic Article
-
First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study Academic Article
-
First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2251 patients Academic Article
-
Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2−advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy Academic Article
-
High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype Academic Article
-
Hormone Receptor and ERBB2 Status in Gene Expression Profiles of Human Breast Tumor Samples Academic Article
-
Identification of a Novel Luminal Molecular Subtype of Breast Cancer Academic Article
-
Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators Academic Article
-
Immunofluorometrically determined p53 accumulation as a prognostic indicator in italian breast cancer patients Academic Article
-
Immunohistochemical evidence for estrogen receptors in meibomian glands Academic Article
-
Incidence of Brain Metastases in Nonmetastatic and Metastatic Breast Cancer: Is There a Role for Screening? Academic Article
-
Induction of hTERT Expression and Telomerase Activity by Estrogens in Human Ovary Epithelium Cells Academic Article
-
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies Academic Article
-
Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes Academic Article
-
Insulin-like growth factor–binding protein-3 and breast cancer survival Academic Article
-
Interactions between endosulfan and dieldrin on estrogen-mediated processes in vitro and in vivo Academic Article
-
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival Academic Article
-
Invasive lobular carcinoma: to grade or not to grade Academic Article
-
Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer? Academic Article
-
Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study Academic Article
-
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy Academic Article
-
Loss of Antigenicity in Stored Sections of Breast Cancer Tissue Microarrays Academic Article
-
Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues Academic Article
-
Managing patients on endocrine therapy: Focus on quality-of-life issues Conference Paper
-
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Academic Article
-
Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes Academic Article
-
Nuclear Kaiso Expression Is Associated with High Grade and Triple-Negative Invasive Breast Cancer Academic Article
-
Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer Academic Article
-
Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer Academic Article
-
Optimal Chemotherapy for Women With Breast Cancer: The Plot Thickens Academic Article
-
Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) Academic Article
-
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27 Academic Article
-
Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations. Academic Article
-
Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4 Academic Article
-
Performance of preoperative breast MRI based on breast cancer molecular subtype Academic Article
-
Pharmacokinetics, safety, activity, and biomarker analysis of palbociclib plus letrozole as first-line treatment for ER+/HER2– advanced breast cancer in Chinese women Academic Article
-
Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study. Academic Article
-
Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women Academic Article
-
Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination Academic Article
-
Polychemotherapy for early breast cancer: an overview of the randomised trials Academic Article
-
Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer Academic Article
-
Postmenopausal breast cancer: is the short-term pain worth the long-term gain? Academic Article
-
Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker Academic Article
-
Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials Academic Article
-
Preparation and Evaluation of Carborane Analogues of Tamoxifen Academic Article
-
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model Academic Article
-
Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: Conference Summary Statement Conference Paper
-
Progesterone Receptor Loss Correlates with Human Epidermal Growth Factor Receptor 2 Overexpression in Estrogen Receptor–Positive Breast Cancer Conference Paper
-
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Academic Article
-
Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Academic Article
-
Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario Academic Article
-
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Academic Article
-
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Academic Article
-
Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer Academic Article
-
Quantitative dot blot analyses of blood-group-related antigens in paired normal and malignant human breast tissues Academic Article
-
RELEVANCE OF THE HORMONE RECEPTOR CONTENT OF PRIMARY TUMORS IN PATIENTS WITH ADVANCED BREAST-CANCER UNDERGOING CYTOTOXIC CHEMOTHERAPY Academic Article
-
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study Academic Article
-
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Academic Article
-
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group. Academic Article
-
Receptor-interacting protein 140 interacts with and inhibits transactivation by, peroxisome proliferator-activated receptor α and liver-X-receptor α Academic Article
-
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative Academic Article
-
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia Academic Article
-
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14 Academic Article
-
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) Academic Article
-
Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma. Academic Article
-
Role of Estrogen in Type 1 and Type 2 Diabetes Mellitus: A Review of Clinical and Preclinical Data Academic Article
-
S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situof the breast Academic Article
-
Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2 Academic Article
-
Safety and efficacy of black cohosh (Cimicifuga racemosa) during pregnancy and lactation. Academic Article
-
Safety and efficacy of chastetree (Vitex agnus-castus) during pregnancy and lactation. Academic Article
-
Secretory Breast Carcinoma: Unique, Triple-Negative Carcinoma With a Favorable Prognosis and Characteristic Molecular Expression Academic Article
-
Serum testosterone levels and breast cancer recurrence Academic Article
-
Systematic Review on Hormone Receptor Testing in Breast Cancer Academic Article
-
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study Academic Article
-
Systemic Adjuvant Therapy for Node-Negative Breast Cancer: Proven or Premature? Academic Article
-
Systemic adjuvant therapy for node-negative breast cancer. Academic Article
-
TAMOXIFEN PROPHYLAXIS Academic Article
-
Tailored targeted therapy for all: a realistic and worthwhile objective against Academic Article
-
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Academic Article
-
Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour Academic Article
-
Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status Academic Article
-
Tamoxifen therapy in premenopausal patients with metastatic breast cancer. Academic Article
-
The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous? Academic Article
-
The First Organometallic Selective Estrogen Receptor Modulators (SERMs) and Their Relevance to Breast Cancer Academic Article
-
The Pattern of Glucocorticoid and Estrogen Receptors May Explain Differences in Steroid Dependency of Intrauterine Prostaglandin Production at Parturition in Sheep Academic Article
-
The best use of adjuvant endocrine treatments Conference Paper
-
The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy Academic Article
-
The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures Academic Article
-
The rapid effects of estrogen: a mini-review Academic Article
-
The standardization of estrogen receptors Academic Article
-
The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling Academic Article
-
Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition Academic Article
-
Treatment of estrogen deficiency symptoms in women surviving breast cancer - Part 6: Executive summary and consensus statement - Proceedings of a conference held at the Boar's Head Inn - Charlottesville, Virginia, September 21-23, 1997 Academic Article
-
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 5: Selective estrogen receptor modulators and hormone replacement therapy. Proceedings of a conference. Charlottesville, Virginia, USA. September 21-23, 1997. Conference Paper
-
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement. Proceedings of a conference held at Boar's Head Inn, Charlottesville, Virginia, September 21-23, 1997. Conference Paper
-
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence Academic Article
-
Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis Academic Article
-
UTILITY OF IN VITRO TEST METHODS TO ASSESS THE ACTIVITY OF XENOESTROGENS IN FISH Academic Article
-
Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk Academic Article
-
Zinc presence in invasive ductal carcinoma of the breast and its correlation with oestrogen receptor status Academic Article
-
[The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma]. Academic Article
-
o,p′-DDT induction of vitellogenesis and its inhibition by tamoxifen in Nile tilapia (Oreochromis niloticus) Academic Article